Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fabbrini

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Neurology|May 1, 1987
3-O-methyldopa and motor fluctuations in Parkinson's diseaseG Fabbrini, J L Juncos, M M Mouradian, et al.
European Journal of Neurology|December 9, 2009
Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasmA Conte, G Fabbrini, D Belvisi, et al.
Journal of Neural Transmission|January 1, 1988
Dopamine D-1 receptor agonist stimulation of prolactin secretion in manG Fabbrini, A Braun, M M Mouradian, et al.
Journal of Neurology|May 7, 2008
Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type AD Tiple, S Strano, C Colosimo, et al.
Parkinsonism & Related Disorders|December 15, 2011
Pathophysiology of pain and fatigue in Parkinson's diseaseA Berardelli, A Conte, G Fabbrini, et al.
European Journal of Neurology|March 8, 2018
Re-emergent tremor in Parkinson's disease: the effect of dopaminergic treatmentD Belvisi, A Conte, C Cutrona, et al.
Journal of Neural Transmission|January 1, 1987
Selective D-1 dopamine receptor agonist treatment of Parkinson's diseaseA Braun, G Fabbrini, M M Mouradian, et al.
Neurology|March 24, 2004
Focal dystonia caused by Mohr-Tranebjaerg syndrome with complete deletion of the DDP1 geneA Pizzuti, G Fabbrini, L Salehi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Camptocormia in Parkinson disease: an epidemiological and clinical studyD Tiple, G Fabbrini, C Colosimo, et al.
Acta Neurologica Scandinavica|March 3, 2001
Donepezil in the treatment of progressive supranuclear palsyG Fabbrini, P Barbanti, V Bonifati, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Neurology|May 1, 1987
3-O-methyldopa and motor fluctuations in Parkinson's diseaseG Fabbrini, J L Juncos, M M Mouradian, et al.
European Journal of Neurology|December 9, 2009
Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasmA Conte, G Fabbrini, D Belvisi, et al.
Journal of Neural Transmission|January 1, 1988
Dopamine D-1 receptor agonist stimulation of prolactin secretion in manG Fabbrini, A Braun, M M Mouradian, et al.
Journal of Neurology|May 7, 2008
Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type AD Tiple, S Strano, C Colosimo, et al.
Parkinsonism & Related Disorders|December 15, 2011
Pathophysiology of pain and fatigue in Parkinson's diseaseA Berardelli, A Conte, G Fabbrini, et al.
European Journal of Neurology|March 8, 2018
Re-emergent tremor in Parkinson's disease: the effect of dopaminergic treatmentD Belvisi, A Conte, C Cutrona, et al.
Journal of Neural Transmission|January 1, 1987
Selective D-1 dopamine receptor agonist treatment of Parkinson's diseaseA Braun, G Fabbrini, M M Mouradian, et al.
Neurology|March 24, 2004
Focal dystonia caused by Mohr-Tranebjaerg syndrome with complete deletion of the DDP1 geneA Pizzuti, G Fabbrini, L Salehi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Camptocormia in Parkinson disease: an epidemiological and clinical studyD Tiple, G Fabbrini, C Colosimo, et al.
Acta Neurologica Scandinavica|March 3, 2001
Donepezil in the treatment of progressive supranuclear palsyG Fabbrini, P Barbanti, V Bonifati, et al.
Pageof 12